JIM DAVIS

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

S. 3486 - Protecting American Advanced Manufacturing Act; Implementation of P.L. 117-169 - the Inflation Reduction Act of 2022.

Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).

Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).

H.R. 1577 - Treat and Reduce Obesity Act of 2021.

H.R. 1577 - Treat and Reduce Obesity Act of 2021.

Regulation of medical gas product manufacturing and cylinders; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356 and S. 2599); FY 2023 appropriations to the Food and Drug Administration; supply chain issues related to medical gases essential to the treatment of COVID-19.

Funding for cancer research, including community health funding and capital funding for cancer centers; pharmacogenic issues related to H.R. 6000 - CURES 2.0; collaboration with the Department of Veterans Affairs.

Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).

Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).

Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).

Funding for cancer research, including community health funding and capital funding for cancer centers; pharmacogenic issues related to H.R. 6000 - CURES 2.0; collaboration with the Department of Veterans Affairs.

Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).

Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).

Funding for cancer facilities and equipment, and for Alcee Hastings Cancer Screening program (FY23 Labor-HHS Appropriations). Funding for collaborative cancer clinical trials (FY23 Mil. Con/VA Appropriations). Retention of precision oncology pharmacogenic provision in CURES 2.0 bill (H.R. 6000).

Regulation of medical gas product manufacturing and cylinders; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356 and S. 2599); FY 2023 appropriations to the Food and Drug Administration; supply chain issues related to medical gases essential to the treatment of COVID-19.

H.R. 3983, Coordination, Accountability, Research and Equity (CARE) for All Kidneys Act of 2021; Including language in the FDA FY22 Appropriations Act (Agriculture, Rural Development, FDA and Related Agencies Appropriations) to encourage the agency to maintain its expertise in perfusion technologies and prioritize review of applications for such technologies; Urging support for associations policy proposals to increase organ transplantation to 50,000 per year; Shortage of crucial solutions to safe organ transplantation.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356 and S. 2599); safeguarding employees of compressed gas manufacturers from COVID-19; supply chain issues related to medical gases essential to the treatment of COVID-19.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356); safeguarding employees of compressed gas manufacturers from COVID-19; implementation of Executive Order 13944 on essential medicines.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356 and S. 2599); safeguarding employees of compressed gas manufacturers from COVID-19; supply chain issues related to medical gases essential to the treatment of COVID-19; OSHA emergency temporary standard on COVID vaccination or testing.

Funding for cancer research, including community health funding and capital funding for cancer centers; pharmacogenic issues related to H.R. 6000 - CURES 2.0; collaboration with the Department of Veterans Affairs.

Funding for cancer research, including community health funding and capital funding for cancer centers; pharmacogenic issues related to H.R. 6000 - CURES 2.0; collaboration with the Department of Veterans Affairs.

Response activities related to coronavirus including vaccination; TREAT Act (H.R. 708); continuation of NextGEN ACOs.

Response activities related to coronavirus including vaccination; TREAT Act (H.R. 708); continuation of NextGEN ACOs.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356 and S. 2599); safeguarding employees of compressed gas manufacturers from COVID-19; supply chain issues related to medical gases essential to the treatment of COVID-19; OSHA emergency temporary standard on COVID vaccination or testing.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2022 appropriations to the Food and Drug Administration Appropriations (H.R. 4356 and S. 2599); safeguarding employees of compressed gas manufacturers from COVID-19; supply chain issues related to medical gases essential to the treatment of COVID-19.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2021 appropriations to the Food and Drug Administration Appropriations in H.R. 133, the Consolidated Appropriations Act of FY 2021; impact of COVID-19 on compressed gas manufacturers; COVID-19 vaccine cold storage; national supply of carbon dioxide.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2021 appropriations to the Food and Drug Administration Appropriations in H.R. 133, the Consolidated Appropriations Act of FY 2021; impact of COVID-19 on compressed gas manufacturers; COVID-19 vaccine cold storage; national supply of carbon dioxide.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2021 Food and Drug Administration Appropriations (H.R. 7610).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2021 Food and Drug Administration Appropriations (H.R. 7610).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2020 Food and Drug Administration Appropriations (H.R. 3164 & S.2522).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2020 Food and Drug Administration Appropriations (H.R. 3164).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2020 Food and Drug Administration Appropriations (H.R. 3164 & S.2522).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2020 Food and Drug Administration Appropriations (H.R. 3164 & S.2522).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2020 Food and Drug Administration Appropriations (H.R. 3164 & S.2522).

Graduate medical education payments and resident caps for hospitals with rotating residents; 340B issues, including proposed cuts to Medicare payment for 340B hospitals; funding for behavioral health and opioid addiction; H.R. 3325, S.428, ACE Kids Act.

Graduate medical education payments and resident caps for hospitals with rotating residents; 340B issues, including proposed cuts to Medicare payment for 340B hospitals; funding for behavioral health and opioid addiction; H.R. 3325, S.428, ACE Kids Act.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2019 Food and Drug Administration Appropriations (H.R. 5961, S.2976).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2019 Food and Drug Administration Appropriations (H.R. 5961, S.2976).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2019 Food and Drug Administration Appropriations (H.R. 5961, S.2976).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2019 Food and Drug Administration Appropriations (H.R. 5961, S.2976).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2019 Food and Drug Administration Appropriations (H.R. 5961, S.2976).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; FY 2019 Food and Drug Administration Appropriations (H.R. 5961, S.2976).

Graduate medical education payments and resident caps for hospitals with rotating residents; 340B issues, including proposed cuts to Medicare payment for 340B hospitals; funding for behavioral health and opioid addiction; H.R. 3325, S.428, ACE Kids Act.

Graduate medical education payments and resident caps for hospitals with rotating residents; 340B issues, including proposed cuts to Medicare payment for 340B hospitals; funding for behavioral health and opioid addiction; H.R. 3325, S.428, ACE Kids Act.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; H.R. 3268 and S.1603, FY 2018 Food and Drug Administration Appropriations; nominations to HHS and FDA.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; implementation of P.L. 115-31, the Consolidated Appropriations Act of 2017; H.R. 3268 and S.1603, FY 2018 Food and Drug Administration Appropriations; nominations to HHS and FDA.

Health care appropriations and authorization issues; Implementation of America's Affordable Health Care Act of 2009; Funding for veteran and behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center.

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center.

Health care appropriations and authorization issues; Implementation of America's Affordable Health Care Act of 2009; Funding for veteran and behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; FY 2017 Food and Drug Administration Appropriations (S.1800 & H.R. 5054).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; FY 2017 Food and Drug Administration Appropriations (S.1800 & H.R. 5054).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; FY 2017 Food and Drug Administration Appropriations (S.1800 & H.R. 5054).

Health care appropriations and authorization issues; Implementation of America's Affordable Health Care Act of 2009; Medicare sustainable growth rate (SGR) formula fix; funding for veteran and behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546.

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Medicare sustainable growth rate (SGR) formula fix; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation of America's Affordable Health Care Act of 2009; Funding for veteran and behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation of America's Affordable Health Care Act of 2009; Medicare sustainable growth rate (SGR) formula fix; funding for veteran and behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546.

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Medicare sustainable growth rate (SGR) formula fix; Medical device tax rule; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation of America's Affordable Health Care Act of 2009; Funding for veteran and behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center; National Cancer Moonshot Initiative.

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center; National Cancer Moonshot Initiative.

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center; National Cancer Moonshot Initiative.

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center; National Cancer Moonshot Initiative.

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center; National Cancer Moonshot Initiative.

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center; National Cancer Moonshot Initiative.

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center; National Cancer Moonshot Initiative.

Work on supporting funding for NIH and the precision medicine initiative via H.R. 6, 21st Century Cures Act; 2017 Labor, Health and Human Services, and Education, and Related Agencies Appropriations; Funding for cancer research through Department of Defense peer reviewed research program and Walter Reed National Military Medical Center; National Cancer Moonshot Initiative.

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; FY 2017 Food and Drug Administration Appropriations (S.1800 & H.R. 5054).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; FY 2017 Food and Drug Administration Appropriations (S.1800 & H.R. 5054).

Regulation of medical gas product manufacturing; implementation of P.L. 112-144, the Food and Drug Administration Safety and Innovation Act; FY 2017 Food and Drug Administration Appropriations (S.1800 & H.R. 5054).

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Medicare sustainable growth rate (SGR) formula fix; Medical device tax rule; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Medicare sustainable growth rate (SGR) formula fix; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation of America's Affordable Health Care Act of 2009; Funding for veteran and behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation of America's Affordable Health Care Act of 2009; Medicare sustainable growth rate (SGR) formula fix; funding for veteran and behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546.

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).

Health care appropriations and authorization issues; Implementation of America's Affordable Health Care Act of 2009; Medicare sustainable growth rate (SGR) formula fix; funding for veteran and behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546.

Health care appropriations and authorization issues; Implementation America's Affordable Health Care Act of 2009; Department of Veterans Affairs funding for behavioral health care; ACE Kids Act of 2015 (S.298/H.R.546).